tradingkey.logo

0.000
Close ETQuotes delayed by 15 min
--Market Cap
--P/E TTM

0.000
More Details of Allurion Technologies Inc Company
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Company Info
Company codeALUR_t
Company nameAllurion Technologies Inc
IPO dateMar 29, 2021
Founded at2023
CEODr. Shantanu Gaur, M.D.
Number of employees- -
Security type- -
Fiscal year-end- -
Address11 Huron Dr Ste 200
CityNATICK
Stock exchange- -
CountryUnited States of America
Postal code01760
Phone15086474000
Websitehttps://www.allurion.com/en
Company codeALUR_t
IPO dateMar 29, 2021
Founded at2023
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Milena Alberti-Perez
Ms. Milena Alberti-Perez
Independent Director
Independent Director
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Ojas A. Buch
Mr. Ojas A. Buch
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
--
--
Mr. Brendan M. Gibbons
Mr. Brendan M. Gibbons
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Milena Alberti-Perez
Ms. Milena Alberti-Perez
Independent Director
Independent Director
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Fri, May 16
Update time: Fri, May 16
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Type
Shareholder
Proportion
Other
100.00%
Institutional Shareholding
Update time: Mon, Feb 24
Update time: Mon, Feb 24
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
75
5.21M
0.00%
-4.68M
2024Q4
88
5.24M
0.00%
-6.81M
2024Q3
98
7.40M
0.00%
-6.25M
2024Q2
101
8.15M
0.00%
-5.37M
2024Q1
100
7.95M
0.00%
-5.42M
2023Q4
99
7.83M
0.00%
-5.49M
2023Q3
99
7.93M
0.00%
-7.42M
2023Q2
93
11.92M
0.00%
-3.44M
2023Q1
92
12.04M
0.00%
-1.65M
2022Q4
86
12.49M
0.00%
+3.26M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Aristeia Capital, L.L.C.
1.23M
0%
--
--
Dec 31, 2024
Public Investment Fund
1.15M
0%
--
--
Dec 31, 2024
Sage Rock Capital Management LP
1.09M
0%
-17.56K
-1.59%
Sep 30, 2024
LMR Partners LLP
319.50K
0%
+319.50K
--
Dec 31, 2024
Clear Street LLC
234.95K
0%
-100.00
-0.04%
Dec 31, 2024
Wolverine Asset Management, LLC
142.05K
0%
--
--
Dec 31, 2024
Saba Capital Management, L.P.
122.68K
0%
--
--
Dec 31, 2024
Davidson Kempner Capital Management LP
97.83K
0%
--
--
Dec 31, 2024
Silver Rock Financial LLC
86.28K
0%
--
--
Dec 31, 2024
Westchester Capital Management, LLC
85.80K
0%
--
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI